相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuromyelitis optica spectrum disorders: still evolving and broadening
Kazuo Fujihara
CURRENT OPINION IN NEUROLOGY (2019)
Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up
Axel Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
S. J. Pittock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Mitsuru Watanabe et al.
NEUROLOGY (2019)
A path to understanding autoimmune GFAP astrocytopathy
A. Zekeridou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
Yuzhen Wei et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6
Yuzhen Wei et al.
NEUROIMMUNOMODULATION (2018)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
Kimihiko Kaneko et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
INFLAMMATORY DEMYELINATION WITHOUT ASTROCYTE LOSS IN MOG ANTIBODY-POSITIVE NMOSD
Justine J. Wang et al.
NEUROLOGY (2016)
Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy A Novel Meningoencephalomyelitis
Boyan Fang et al.
JAMA NEUROLOGY (2016)
Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease
Axel Petzold
BRAIN RESEARCH (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody
Kensuke Ikeda et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease
Romana Hoeftberger et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
Douglas Kazutoshi Sato et al.
ANNALS OF NEUROLOGY (2014)
Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization
Hans-Gert Bernstein et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2014)
The investigation of acute optic neuritis: a review and proposed protocol
Axel Petzold et al.
NATURE REVIEWS NEUROLOGY (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Yujuan Jiao et al.
NEUROLOGY (2013)
Aquaporin-4 antibody-negative neuromyelitis optica Distinct assay sensitivity-dependent entity
Romain Marignier et al.
NEUROLOGY (2013)
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays
Romana Hoeftberger et al.
PLOS ONE (2013)
Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol
Megan K. Herbert et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Aquaporin 4 and neuromyelitis optica
Marios C. Papadopoulos et al.
LANCET NEUROLOGY (2012)
Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases
A. Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
Romain Marignier et al.
BRAIN (2010)
Astrocytic damage is far more severe than demyelination in NMO A clinical CSF biomarker study
R. Takano et al.
NEUROLOGY (2010)
Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
T. Misu et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
C. E. Teunissen et al.
NEUROLOGY (2009)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
VA Lennon et al.
LANCET (2004)
Measurement of glial fibrillary acidic protein in blood: an analytical method
WJA van Geel et al.
CLINICA CHIMICA ACTA (2002)
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
P Werner et al.
ANNALS OF NEUROLOGY (2001)
分享论文
